1. Drug discount program: update on agency efforts to improve 340B program oversight : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives Publication: Washington, D.C. : U.S. Government Accountability Office, July 18, 2017 Subject(s): Government RegulationInsurance, Pharmaceutical Services -- economicsMedicaid -- economicsContract ServicesEconomics, PharmaceuticalForecastingGovernment Programs -- statistics & numerical dataInsurance, Health, ReimbursementPharmacies -- statistics & numerical dataPharmacies -- trendsHumansUnited StatesUnited States. Health Resources and Services Administration.
